Neo-Bio-ADAURA: a Phase II Study to Evaluate Mechanisms of Resistance to Neoadjuvant Osimertinib
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Non-squamous NSCLC
Related studies linked through entity extraction aliases.
Study of Polymeric Micellar Paclitaxel, Platinum Combined With Sindilizumab Injection for Advanced Non-squamous NSCLC
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Pembrolizumab Plus Bevacizumab and Chemotherapy for Non-Squamous NSCLC Patients
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Atezolizumab Plus Bevacizumab and Chemotherapy in First-Line Metastatic Nonsquamous NSCLC
- Status
- COMPLETED
- Phase
- N/A
A Study of ABP 215 Versus Bevacizumab in Chinese Subjects With Advanced Non-Squamous Non-Small Cell Lung Cancer
- Status
- WITHDRAWN
- Phase
- PHASE3
Phase 3 Study of Pyrotinib Versus Docetaxel in Patients With Advanced Non-squamous NSCLC Harboring a HER2 Exon 20 Mutation Who Failed Platinum Based Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE3
AFAMOSI: Efficacy and Safety of Afatinib Followed by Osimertinib Compared to Osimertinib in Patients with EGFRmutated/T790M Mutation Negative Nonsquamous NSCLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE4
Study of Anlotinib in Non-squamous NSCLC Patients Who Failed First-Line（ALTER-L020）
- Status
- UNKNOWN
- Phase
- PHASE4
Study for Treatment With TH-4000 (Tarloxotinib) in Epidermal Growth Factor Receptor (EGFR) Mutant, T790M-negative Non-small Cell Lung Cancer (NSCLC) Patients
- Status
- TERMINATED
- Phase
- PHASE2